Time Warp: Fax Machines Still Common in Oncology Practice. Why?July 3, 2024Practice ManagementBreast CancerCNS/Brain CancerDLBCLFollicular LymphomaGastrointestinal CancerGene Therapy
Doctors Endorsing Products on X May Not Disclose Company TiesJune 19, 2024Practice ManagementBreast CancerCNS/Brain CancerDLBCLFollicular LymphomaGastrointestinal CancerGene Therapy
Survey Spotlights Identification of Dermatologic Adverse Events From Cancer TherapiesMay 13, 2024Mixed TopicsBreast CancerCNS/Brain CancerDLBCLFollicular LymphomaGastrointestinal CancerGenitourinary Cancer
Most Targeted Cancer Drugs Lack Substantial Clinical BenefitApril 17, 2024Practice ManagementBreast CancerCNS/Brain CancerDLBCLFollicular LymphomaGastrointestinal CancerGenitourinary Cancer
Less Than 50% of Accelerated Approvals Show Clinical BenefitApril 9, 2024Practice ManagementBreast CancerCNS/Brain CancerDLBCLFollicular LymphomaGastrointestinal CancerGenitourinary Cancer
Unleashing Our Immune Response to Quash CancerFebruary 21, 2024Immuno-oncologyGene TherapyMixed TopicsPatient & Survivor CarePediatricsDLBCLDiversity in Medicine
FDA places clinical hold on sickle cell gene therapyMarch 2, 2021Leukemia, Myelodysplasia, TransplantationGene Therapy
ICYMI: NIH renames, streamlines gene therapy committeeApril 26, 2019Immuno-oncologyImmunotherapyGene Therapy
Barriers to CAR T use in the spotlight at first European meetingFebruary 28, 2019Immuno-oncologyImmunotherapyGene Therapy
CMS proposes coverage of CAR T-cell therapy in trialsFebruary 15, 2019Practice ManagementImmuno-oncologyImmunotherapyGene Therapy
Feds aim to streamline gene therapy oversightAugust 16, 2018Practice ManagementImmuno-oncologyGene Therapy
Payers part of the drug-pricing problem, says FDA commissionerMarch 7, 2018Practice ManagementGene Therapy
Experts call for international cooperation on human gene editingDecember 3, 2015PediatricsRare DiseasesGene Therapy
